SR
Synaptic Research League at IDWeek 2026
Oct 21–24, 2026 Washington, DC ~12k attendees Website
Synaptic Research League brings 3 presentations to IDWeek 2026 in Washington. Its program centres on HIV treatment and on hard-to-treat bloodstream and heart valve infections. It compares islatravir-doravirine with integrase inhibitor regimens, and weighs PCR, sequencing and metagenomic sequencing for endocarditis when blood cultures are negative.
| Organization | IDWeek 2026 Attendance |
|---|---|
SR Synaptic Research League | |
Poster Fri Oct 23 12:15pm–1:30pm Comparative efficacy and safety of Islatravir–Doravirine versus integrase inhibitor–based triple antiretroviral therapy in HIV-1 infection: a systematic review Poster Sat Oct 24 12:15pm–1:30pm Bacteriemia Enterocócica Persistente (≥72h Despite Appropriate Antibiotic Therapy) Poster Sat Oct 24 12:15pm–1:30pm Molecular Diagnostic Approaches in Blood Culture–Negative Infective Endocarditis: A Comparison of PCR, Sequencing, and Metagenomic Next-Generation Sequencing |
Instantly find 20 buyers from Synaptic Research League
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by IDWeek, the Infectious Diseases Society of America (IDSA) or its partner societies (SHEA, HIVMA, PIDS and SIDP). Submit a correction